echoloc

Epredia Tech Stack

Precision cancer diagnostics through anatomical pathology instruments and software

Biotechnology Research Portsmouth, New Hampshire 1,001–5,000 employees Founded 2019 Privately Held

Epredia manufactures and distributes specialized instruments, reagents, and software for cancer pathology labs globally. The tech stack reflects a manufacturing-first business—heavy on CAD (Creo, SolidWorks), ERP (SAP), and regulatory compliance tooling (HL7, SNOMED, IEC 62304, ISO 13485)—paired with emerging software capabilities (React, Node.js, image management platform). Active hiring skews toward sales and manufacturing roles, and project focus spans both operational efficiency (6S audits, DFM/DFA on refrigeration) and revenue expansion (digital pathology portfolio, territory planning), signaling a shift from pure instrument sales toward software and services.

Tech Stack 29 technologies

Core StackSalesforce SAP Power BI C++ C# Python SolidWorks JavaScript PostgreSQL Jira Bitbucket Node.js React Workday Creo Qt ServiceMax .NET Framework NET Core WPF Windows Forms ASP.NET MVC SQLite TIFF HL7 SNOMED IEC 62304 ISO 13485 OpenGL

What Epredia Is Building

Challenges

  • Expanding market share in digital pathology
  • Increasing service revenue
  • Data integrity issues
  • Efficiency gains
  • Billing accuracy
  • Expanding digital pathology portfolio
  • Identifying new market opportunities
  • Expanding anatomical pathology market
  • Improving safety awareness
  • Enhancing quality control

Active Projects

  • 6s implementation audits
  • Practical process improvement (ppi)
  • Global growth of image management software and ai portfolio
  • Implement trade and regulatory compliance policy
  • Anatomical pathology portfolio sales
  • Territory account planning
  • Training and go-to-market support
  • Product demos and installations
  • 30-60-90 funnel activity development for instrument systems
  • Dfm and dfa initiatives for refrigeration systems

Hiring Activity

Accelerating30 roles · 30 in 30d

Department

Sales
7
Engineering
6
Manufacturing
5
Logistics
2
Ops
2
Support
2
Finance
1
Operations
1

Seniority

Mid
14
Junior
5
Senior
5
Manager
4
Intern
1
Company intelligence

Find more companies like Epredia by tech stack, pain points and active projects

Get started free

About Epredia

Epredia is a precision cancer diagnostics company serving anatomical pathology laboratories with tissue processing equipment, microscope slides, staining systems, and image management software. Founded in 2019 as a PHC Group acquisition from Thermo Fisher Scientific, the company operates under trusted brands including Shandon, Microm, Menzel Gläser, and Richard-Allan Scientific, with roots tracing to 1937. The product portfolio spans tissue embedding, microtomy, cryotomy, cassette printing, and slide management—deployed over a billion times annually across global pathology workflows. Epredia is headquartered in Portsmouth, New Hampshire, and employs 1,001–5,000 people across United States, Italy, and China manufacturing and sales operations.

HeadquartersPortsmouth, New Hampshire
Company Size1,001–5,000 employees
Founded2019
Hiring MarketsUnited States, Italy, China

Frequently Asked Questions

What is Epredia's tech stack?

Epredia uses Salesforce (CRM), SAP (ERP), Power BI (analytics), and Workday (HR). Engineering stack includes C++, C#, .NET Framework/.NET Core, Python, React, and Node.js. CAD tools are Creo and SolidWorks. Regulatory/standards compliance: HL7, SNOMED, IEC 62304, ISO 13485.

What is Epredia working on?

Current focus areas include digital pathology portfolio expansion, image management software and AI development, trade/regulatory compliance policy implementation, anatomical pathology portfolio sales growth, territory account planning, and manufacturing efficiency initiatives (6S audits, DFM/DFA on refrigeration systems).

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

How this profile is built

Epredia's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.